Year-over-year earnings per share growth for the last twelve months: Leap Therapeutics, Inc. (LPTX)

Leap Therapeutics (LPTX) - corporate logo

The antibody development ecosystem retains patients with advanced gastrointestinal cancer through a network of US oncology centers. The quarterly EPS trend on GURU.Markets reflects resource management efficiency, where the value 22.00 represents the metric balance. Leap Therapeutics, Inc. (LPTX) management is focusing on integrating targeted therapies into current treatment protocols. Strategic alliances with major partners in the creation of DKN-01 enhance scientific synergy and patient survival rates.

Leap Therapeutics Inc (LPTX) Year-over-year net earnings per share growth for the last 12 months: for the period 07/04/2022 - 11/13/2025

Comprehensive metric breakdowns and analytics for Leap Therapeutics (LPTX)

Comprehensive company analysis:Leap Therapeutics, Inc., LPTX
Manufactured product of leaptx.com

This indicator measures the quarterly dynamics of net earnings per share, allowing for the filtering of short-term market anomalies and the assessment of real capital generation efficiency. By analyzing the quarterly change in earnings per share, an investor can confirm the fundamental stability of Leap Therapeutics, Inc. (LPTX), whose value is currently driven by the internal development of oncology drugs until their future licensing to global pharmaceutical behemoths.

Competitors of Leap Therapeutics, Inc.

IBRX: Quarterly EPS earnings growth|IMCR - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months januxrx.com|Year-over-year net earnings per share growth for the last 12 months arcusbio.com (RCUS)|Year-over-year earnings per share growth for the last twelve months Zymeworks Inc (ZYME)|Year-over-year net earnings per share growth for the last 12 months Tango Pharma TNGX|Iovance Biotherapeutics Inc - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Immatics Biotechnologies IMTX|XNCR - Year-over-year earnings per share growth for the last twelve months|CMPX (compasstherapeutics.com) - Year-over-year earnings per share growth for the last 12 months|Replimune Inc. (REPL) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Lyell Immunopharma Inc (LYEL)|Year-over-year net earnings per share growth for the last 12 months IPHA|PYXS - Net earnings per share growth for the trailing year|Year-over-year net earnings per share growth for the last 12 months CGEN (Compugen Ltd.)|Year-over-year earnings per share growth rate for the last twelve months IOBT|Quarterly EPS earnings growth STRO (Sutro Biopharma)|Year-over-year earnings per one share growth for the last 12 months INKT|Werewolf - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Immix Biopharma|ALX Oncology (ALXO) - Year-over-year earnings per share growth for the last twelve months|cuebiopharma.com (CUE) - Quarterly EPS earnings growth|PDSB (PDS Biotechnology Corp) - Quarterly EPS earnings growth|Quarterly EPS earnings growth sonnetbio.com|Year-over-year earnings per share growth for the last twelve months MAIA Biotechnology, Inc. (MAIA)|LIMN: Year-over-year net earnings per share trend for the last twelve months|LAVA Therapeutics - Year-over-year net earnings per share growth for the last 12 months|nextcure.com (NXTC) - Earnings per share growth in annualized terms for the last twelve months|Intensity Therapeutics Inc - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months senseibio.com SNSE|TOVX: Quarterly EPS earnings growth|Gritstone bio Inc. - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months KA|Year-over-year earnings per share growth for the last 12 months NEXI (NexImmune, Inc.)|Year-over-year earnings per share growth for the last twelve months Turnstone Biologics Corporation (TSBX)|Year-over-year net earnings per share growth for the last 12 months Vaccinex VCNX|Year-over-year earnings per share growth for the last twelve months harpoontx.com HARP